NCT00104897 2013-06-2617-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant MelanomaNational Cancer Institute (NCI)Phase 2 Completed25 enrolled
NCT00004065 2013-06-24Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00004241 2013-02-0717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaNational Cancer Institute (NCI)Phase 1 Completed60 enrolled
NCT00004075 2011-08-0317-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryMayo ClinicPhase 1 Completed